VCCBH News


TGIR Research Slam Highlights Progress One Year into Pandemic

April 7, 2021 by Jennifer Nachbur

On March 18, 2021, researchers from across UVM came together via Zoom for the second edition of the Translational Global Infectious Diseases Research Center's COVID-19 research slam, titled “UVM Tackles COVID-19: Research Progress and Perspectives One Year into the Pandemic.”

Cassandra Ventrone, research technician in UVM's Vaccine Testing Center, processes materials for the AstraZeneca COVID-19 vaccine trial. (Photo: Ryan Mercer, UVM Medical Center)

As the hub of infectious disease research at the Larner College of Medicine, the Translational Global Infectious Diseases Research (TGIR) Center proactively led a research slam about “2019-nCoV” – a quickly spreading novel coronavirus originating from Wuhan, China – in February 2020. Over the past 14 months since, basic scientists and clinicians from across the University of Vermont have conducted a total of 77 COVID-19 research projects. On March 18, 2021, the researchers came together again for the second edition of this gathering.

Titled “UVM Tackles COVID-19: Research Progress and Perspectives One Year into the Pandemic,” the research slam was organized and hosted via Zoom by TGIR Principal Investigator Beth Kirkpatrick, M.D., chair of microbiology and molecular genetics and director of the Vaccine Testing Center, and Kristen Pierce, M.D., professor of medicine and TGIR Health Population Research Core director. The 2021 event featured an opening presentation by Vermont Commissioner of Health Mark Levine, M.D., and keynote address on “How COVID-19 Has Changed the Field of Infectious Disease Modeling" by Caroline Buckee, Ph.D., associate professor of epidemiology and associate director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health.

Faculty from departments and colleges across the university concurrently delivered presentations during break-out sessions grouped in the following categories: Clinical/Translational Research (moderated by Dr. Pierce); Epidemiology and Public Health Section 1 (moderated by Dr. Kirkpatrick); Epidemiology and Public Health Section 2 (moderated by Jason Bates, Ph.D., D.Sc.); Basic Science (moderated by Christopher Huston, M.D.); Modeling (moderated by Dr. Buckee); and Environment/Climate/Ecology (moderated by E. Ross Colgate, Ph.D.). (Link to the full event agenda.)

“For many of us, the last year has been so difficult and at times frightening,” says Pierce. “The research slam was a chance for us to highlight and share details about the amazing research efforts that took place in response to the pandemic. And personally, it was wonderful to see so many of my colleagues’ faces on the other side of 2020.”

Among the Clinical/Translational Research session topics was a presentation by Mary Cushman, M.D., M.Sc., professor of medicine, about the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, and in particular the RAPID COVID COAG anticoagulation trial on which she served as an investigator. Cushman discussed details about the anticoagulation research effort, which featured what she called “harmonized protocols” delivered via multiple platforms to determine whether there was a greater benefit from administering full doses of blood thinners to moderately ill hospitalized patients with COVID-19. She noted that 32 percent of trial participants were Black or Hispanic – an important achievement in light of the disproportionate impact of COVID-19 on BIPOC communities. She also underscored the remarkably short timeframe between the launch of the ACTIV-4 Antithrombotics inpatient clinical trial in September 2020 and release of results – which found that full dose blood-thinning treatment reduced the need for such critical organ support as mechanical ventilation – in January 2021.  

One of the research projects in the Epidemiology and Public Health Section 1 session was a presentation, titled "Healthcare worker COVID infection epidemiology," by Cindy Noyes, M.D., associate professor of medicine and director of infection prevention and hospital epidemiologist at the UVM Medical Center. This project highlighted protocols implemented at the medical center, including a designated COVID hotline and contact tracing process, and tracked the number of COVID-19-positive employees at the UVM Medical Center over time and in the context of the implementation of interventions like visitor restriction, universal masking for all staff and patients, the addition of eye protection, and employee vaccination.

Noyes pointed out that the medical center employee patterns of infection followed the state infection rates and noted that “probably the most impactful intervention was employee vaccination, which began on December 15,” and resulted in a marked decrease in cases one month later. Another interesting finding of the research was that of 193 COVID-19-positive employees, 126 or 65 percent were community-acquired, non-work-related infections.

Presenters included medical students and faculty representing departments and programs, including biology; biomedical and health sciences; civil and environmental engineering; environmental sciences; family medicine; geography; medicine; microbiology and molecular genetics; nutrition and food sciences; pathology and laboratory medicine; pediatrics; and surgery.



Recent Stories and Publications Featuring VCCBH Members


Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 2, 2024

Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted August 21, 2024

Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5 at Magdalen College in Oxford, United Kingdom.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 31, 2024

A collaborative research team co-led by investigators David Jangraw, Ph.D., M.S., and Denise Peters, Ph.D., D.P.T., PT, has been awarded the 2024 Armin Grams Memorial Research Award by the Center on Aging. 

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 10, 2024

Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis Center.

Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases

Posted May 15, 2024

John Salogiannis, Ph.D., assistant professor of molecular physiology and biophysics, and members of his lab team—Allison (Morrissey) Langley, lab technician and Ph.D. candidate in cellular, molecular, and biomedical sciences; Sarah Abeling-Wang, lab research technician; and Erinn Wagner, UVM undergraduate biology major—have their first preprint*: “Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases.” The team’s research is supported by an NIH Maximizing Investigators’ Research Award (MIRA or R35) for early-stage investigators.

The University of Vermont Center on Aging Newsletter

Posted May 2024

Katharine Cheung, M.D., Ph.D., M.Sc., interim director of the UVM Center on Aging, associate director for research, and assistant professor of medicine, and her mentee, medical student Susanna Schuler ’26, presented their research findings at the American Academy of Hospice and Palliative Medicine State of the Science meeting on March 23 in Phoenix, Arizona.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted March 6, 2024

A study by a nationwide collaborative group, including Larner scientists Mary Cushman, M.D., M.Sc., University of Vermont Distinguished Professor and co-director of the Vermont Center for Cardiovascular and Brain Health, Russell Tracy, Ph.D., University of Vermont Distinguished Professor and director of UVM’s Laboratory for Clinical Biochemistry Research, Margaret Doyle Ph.D., associate professor of Pathology and Laboratory Medicine and co-director of the Laboratory of Clinical Biochemistry, and Rebekah Boyle, M.S., was recently published in Nature Communications.

 

UVM Scientist Wins Chan Zuckerberg Initiative Grant to Tackle Neurodegenerative Diseases

Larner Scientist Seeks to Advance Neurodegeneration Research

February 22, 2024

Larner College of Medicine scientist Osama Harraz, Ph.D., M.Sc., and his colleague from the University of Maryland (UMD), Thomas Longden, Ph.D., are recipients of a prestigious Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network (NCDN).